http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101152876-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y402-01047 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-01073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y504-02008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y101-01271 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-00 |
| filingDate | 2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101152876-B1 |
| titleOfInvention | Method for Production of GPD-fucose in Recombinant Escherichia Coli by Further Expression of Guanosine-Inosine Kinase |
| abstract | In addition to overexpression of related enzymes that mediate the synthetic pathway of GDP-fucose, the present invention is directed to recombinant E. coli recombinantly overexpressing glucose-6-phosphate-dehydrogenase or / and guanosine-inosine kinase. On how to produce GDP-fucose Using a recombinant E. coli co-expressing glucose-6-phosphate dehydrogenase (G6PDH) and ManB, ManC, Gmd and WcaG, a representative NADPH reproductive enzyme present in E. coli, pH-stat fed-batch culture produced up to 235.2 ± 3.3 mg / L of GDP-fucose, a 21% improvement over recombinant E. coli without G6PDH. In addition, using recombinant E. coli additionally expressing guanosine-inosine kinase (Gsk), GDP-fucose of up to 305.5 ± 5.3 mg / L was produced in a fed-batch culture of pH-stat method. This is a 58% improvement over recombinant E. coli without further expression of Gsk. |
| priorityDate | 2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 482.